Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Sarah Halford,
Susan Wan,
Ilaria Dragoni,
Julie Silvester,
Bobojon Nazarov,
Daniel Anthony,
Suzie Anthony,
Emma Ladds,
John Norrie,
Kevin Dhaliwal,
and the CDD SPIKE-1 Project Team
Affiliations
Sarah Halford
Cancer Research UK Centre for Drug Development
Susan Wan
Cancer Research UK Centre for Drug Development
Ilaria Dragoni
Cancer Research UK Centre for Drug Development
Julie Silvester
Cancer Research UK Centre for Drug Development
Bobojon Nazarov
Latus Therapeutics
Daniel Anthony
University of Oxford
Suzie Anthony
Oxford University Hospitals NHS Foundation Trust
Emma Ladds
Nuffield Department of Primary Care Health Sciences, University of Oxford
